As of April 16, 2025, LivaNova (LIVN) has a market cap of $1.88 billion USD. According to our data, LivaNova is ranked No.4072 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $1.88 B |
-25.41%
|
Dec 31, 2024 | $2.51 B |
-10.49%
|
Dec 29, 2023 | $2.81 B |
-6.84%
|
Dec 30, 2022 | $3.02 B |
-36.47%
|
Dec 31, 2021 | $4.75 B |
32.05%
|
Dec 31, 2020 | $3.60 B |
-12.22%
|
Dec 31, 2019 | $4.10 B |
-17.54%
|
Dec 31, 2018 | $4.97 B |
14.45%
|
Dec 29, 2017 | $4.34 B |
77.72%
|
Dec 30, 2016 | $2.44 B |
-24.25%
|
Dec 31, 2015 | $3.22 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Medtronic
MDT
|
$105.64 B |
0.002 M
|
![]() Ireland
|
![]() Boston Scientific
BSX
|
$139.37 B |
0.007 M
|
![]() USA
|
![]() Edwards Lifesciences
EW
|
$41.45 B |
0.000 M
|
![]() USA
|
![]() Abbott Laboratories
ABT
|
$218.91 B |
-0.002 M
|
![]() USA
|
![]() Zimmer Biomet
ZBH
|
$19.24 B |
0.000 M
|
![]() USA
|
![]() Stryker Corporation
SYK
|
$132.37 B |
-0.002 M
|
![]() USA
|
![]() Becton Dickinson
BDX
|
$58.01 B |
-0.001 M
|
![]() USA
|
![]() Smith & Nephew
SNN
|
$11.39 B |
0.000 M
|
![]() UK
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() Getinge
GETI-B.ST
|
$5.38 B |
0.295 B
|
![]() Sweden
|
![]() Fresenius Medical Care
FMS
|
$14.68 B |
-0.000 M
|
![]() Germany
|
![]() Philips
PHG
|
$22.06 B |
19.779 M
|
![]() Netherlands
|
![]() Baxter
BAX
|
$14.26 B |
0.000 M
|
![]() USA
|
Market Cap | = | LIVN Stock Price | * | LIVN Shares Outstanding |
= | $34.51 | * | 54.35 M | |
= | $1.88 B |